Arcutis Biotherapeutics Executive Disposes of Shares to Meet Tax Obligations
Patrick Burnett, serving as the Executive Vice President and Chief Medical Officer for Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), has completed a sale of common stock. The transaction, which occurred on May 11, 2026, involved 222 shares sold at a price of $21.05 per share, totaling $4,673. This specific disposal was conducted to address tax with…